We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOHU
3151
Sohu.com
SOHU
$357M
$126K ﹤0.01%
12,686
+1,175
+10% +$10.5K
HCM icon
3152
HUTCHMED
HCM
$2.17B
$125K ﹤0.01%
6,910
-1,194
-15% -$21.7K
RTO icon
3153
Rentokil
RTO
$12.2B
$124K ﹤0.01%
4,346
+42
+1% +$1.23K
SMTI icon
3154
Sanara MedTech
SMTI
$313M
$124K ﹤0.01%
3,021
-105
-3% -$3.37K
LKFT
3155
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$123K ﹤0.01%
3,036
PROK icon
3156
ProKidney
PROK
$337M
$123K ﹤0.01%
69,208
+564
+0.8% +$1.21K
NSANY
3157
DELISTED
NISSAN MOTOR CO LTD SPONS ADR
NSANY
$123K ﹤0.01%
15,679
+658
+4% +$5.16K
LICY
3158
DELISTED
Li-Cycle Holdings Corp.
LICY
$122K ﹤0.01%
26,071
+1
+0% +$11
BSVN icon
3159
Bank7 Corp
BSVN
$481M
$122K ﹤0.01%
4,452
-5,389
-55% -$128K
WFG icon
3160
West Fraser Timber
WFG
$5.65B
$122K ﹤0.01%
1,420
LCTX icon
3161
Lineage Cell Therapeutics
LCTX
$278M
$121K ﹤0.01%
111,456
+481
+0.4% +$527
CX icon
3162
Cemex
CX
$16.3B
$121K ﹤0.01%
15,674
IVAC
3163
DELISTED
Intevac Inc
IVAC
$121K ﹤0.01%
28,113
-313
-1% -$1.17K
FROG icon
3164
JFrog
FROG
$10.8B
$120K ﹤0.01%
3,474
CDZI icon
3165
Cadiz
CDZI
$291M
$120K ﹤0.01%
42,840
-310
-0.7% -$935
INDY icon
3166
iShares S&P India Nifty 50 Index Fund
INDY
$569M
$120K ﹤0.01%
2,430
KPTI icon
3167
Karyopharm Therapeutics
KPTI
$48M
$119K ﹤0.01%
9,207
-3
-0% -$40
SNFCA icon
3168
Security National Financial
SNFCA
$251M
$119K ﹤0.01%
15,264
+130
+0.9% +$894
GBIO
3169
DELISTED
Generation Bio
GBIO
$119K ﹤0.01%
7,187
+49
+0.7% +$854
OPTN
3170
DELISTED
OptiNose
OPTN
$118K ﹤0.01%
6,085
+1,667
+38% +$30.4K
EWN icon
3171
iShares MSCI Netherlands ETF
EWN
$637M
$118K ﹤0.01%
2,638
ERF
3172
DELISTED
Enerplus Corporation
ERF
$118K ﹤0.01%
7,670
SGMO
3173
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$117K ﹤0.01%
215,207
-90
-0% -$41
TUSK icon
3174
Mammoth Energy Services
TUSK
$163M
$117K ﹤0.01%
26,175
+218
+0.8% +$967
HNP
3175
DELISTED
Huaneng Power Intl, Inc.
HNP
$116K ﹤0.01%
6,263
-6,553
-51% -$122K

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.